Dose of progestin in postmenopausal-combined hormone therapy and risk of endometrial cancer
Open Access
- 31 October 2004
- journal article
- Published by Elsevier BV in American Journal of Obstetrics and Gynecology
- Vol. 191 (4), 1146-1151
- https://doi.org/10.1016/j.ajog.2004.04.041
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Effects of Estrogen Plus Progestin on Gynecologic Cancers and Associated Diagnostic ProceduresThe Women's Health Initiative Randomized TrialJama-Journal Of The American Medical Association, 2003
- Patterns of postmenopausal progestin use with estrogen in relation to endometrial cancer (United States).Cancer Causes & Control, 2003
- The NICHD Women's Contraceptive and Reproductive Experiences Study: Methods and Operational ResultsAnnals of Epidemiology, 2002
- Continuous combined hormone replacement therapy and risk of endometrial cancerAmerican Journal of Obstetrics and Gynecology, 2000
- Hormone replacement therapy and endometrial cancer in Ontario, CanadaJournal of Clinical Epidemiology, 2000
- Risk of Endometrial Cancer Following Estrogen Replacement With and Without ProgestinsJNCI Journal of the National Cancer Institute, 1999
- Estrogen-Progestin Replacement Therapy and Endometrial CancerJNCI Journal of the National Cancer Institute, 1997
- Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal womenThe Lancet, 1997
- Hormone replacement therapy and endometrial cancer risk: A meta-analysisObstetrics & Gynecology, 1995
- Sampling Methods for Random Digit DialingJournal of the American Statistical Association, 1978